The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000152.5(GAA):c.1332T>C (p.Pro444=)

CA8815288

286018 (ClinVar)

Gene: GAA
Condition: glycogen storage disease II
Inheritance Mode: Autosomal recessive inheritance
UUID: 6677c5dc-80b2-4ac1-b197-6c8a76d3a6a9

HGVS expressions

NM_000152.5:c.1332T>C
NM_000152.5(GAA):c.1332T>C (p.Pro444=)
NC_000017.11:g.80109950T>C
CM000679.2:g.80109950T>C
NC_000017.10:g.78083749T>C
CM000679.1:g.78083749T>C
NC_000017.9:g.75698344T>C
NG_009822.1:g.13395T>C
ENST00000302262.8:c.1332T>C
ENST00000302262.7:c.1332T>C
ENST00000390015.7:c.1332T>C
NM_000152.3:c.1332T>C
NM_001079803.1:c.1332T>C
NM_001079804.1:c.1332T>C
NM_000152.4:c.1332T>C
NM_001079803.2:c.1332T>C
NM_001079804.2:c.1332T>C
NM_001079803.3:c.1332T>C
NM_001079804.3:c.1332T>C

Likely Benign

Met criteria codes 3
BP7 BP4 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Lysosomal Storage Disorders Variant Curation Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
The NM_000152.5:c.1332T>C (p.Pro444=) variant in GAA is a synonymous (silent) variant that is not predicted to impact splicing; the nucleotide is not highly conserved (PhyloP 100 way score is -2.4 (BP4, BP7). There is a ClinVar entry for this variant (Variation ID: 286018). In summary, this variant meets the criteria to be classified as likely benign for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases VCEP (Specifications Version 2.0): BS1, BP4, BP7. (Classification approved by the ClinGen Lysosomal Diseases VCEP, March 13, 2023).
Met criteria codes
BP7
The NM_000152.5:c.1332T>C (p.Pro444=) variant in GAA is a synonymous (silent) variant that is not predicted to impact splicing; the nucleotide is not highy conserved (PhyloP 100 way score is -2.4 (BP7).
BP4
The computational splicing predictor SpliceAI suggests that the variant has no impact on splicing (BP4).
BS1
The highest population minor allele frequency in gnomAD v2.1.1 is 0.00859 (171/19912 alleles; including one homozygote) in the East Asian population, which is higher than the ClinGen Lysosomal Diseases VCEP threshold (>0.005) for BS1, and meets this criterion.
Approved on: 2023-03-13
Published on: 2023-03-13
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.